P. Filipe et al. / Biochemical Pharmacology 67 (2004) 2207–2218
2209
OBn
dichloromethane (20 ml) and purified by silica gel column
chromatography using dichloromethane as eluent. This
solvent was evaporated to dryness and the residue was
then crystallized from ethanol giving 1-(2-hydroxyphenyl)-
5-(3,4-dibenzyloxyphenyl)-3-hydroxy-2,4-pentadiene-1-
one (2) (2.0 g, yield: 84%). m.p. 133–136 8C (recrystallized
from ethanol). 1H NMR: d ¼ 5:21 (s, 2H, 300-OCH2C6H5),
5.22 (s, 2H, 400-OCH2C6H5), 6.28 (s, 1H, H-2), 6.40 (d, J
15.7 Hz, 1H, H-4), 6.90 (ddd, J 8.5, 7.6 and 1.0 Hz, 1H,
H-50), 6.94 (d, J 8.4 Hz, 1H, H-500), 6.99 (dd, J 8.4 and
1.0 Hz, 1H, H-30), 7.12 (dd, J 8.4 and 1.9 Hz, 1H, H-600),
7.16 (d, J 1.9 Hz, 1H, H-200), 7.30–7.49 (m, 11H, H-40 and
H-2,3,4,5,6 of 300,400-OCH2C6H5), 7.55 (d, J 15.7 Hz, 1H,
H-5), 7.69 (dd, J 8.5 and 1.5 Hz, 1H, H-60), 12.27 (s, 1H, 20-
OH), 14.72 (s, 1H, 3-OH). 13C NMR: d ¼ 70:9 (400-
OCH2C6H5), 71.4 (300-OCH2C6H5), 96.5 (C-2), 113.7
(C-200), 114.3 (C-500), 118.7 (C-30), 119.0 (C-50), 119.1
(C-10), 120.1 (C-4), 122.9 (C-600), 127.2, 127.3, 127.5,
128.0 and 128.4 (C-2,3,4,5,6 of 300,400-OCH2C6H5), 128.4
(C-60), 135.7 (C-40), 136.7 and 136.9 (C-100 and C-1 of 300,400-
OCH2C6H5), 139.8 (C-5), 149.0 (C-300), 151.0 (C-400), 162,5
(C-20), 174.9 (C-3), 195.6 (C-1). EI-MS: m/z (%) ¼ 478 (8)
(Mꢀþ), 387(3), 369(2), 181(4), 163(3), 121(18), 92(11),
91(100), 77(2), 65(10), 63(2), 51(2). C31H26O5 (478.5):
Calc. C, 77.81; H, 5.48. Found C, 77.94; H, 5.52.
O
OBn
CO2H
BnO
O
+
A
OH
O
BnO
O
1
OBn
OBn
B
5’
5"
2"
OBn
6"
O
4’
3’
6’
4"
C
4
2
5
3
1
3"
OBn
2’
OH
O
HO
O
3
2
D
5’
4’ OH
6’
3’
β
OH
2’
8
5
A: POCl3, dry pyridine
B: KOH, DMSO
9
O
4
α
7
6
2
C: p-Toluenesulfonic acid, DMSO
D: HBr/Acetic acid
3
10
O
SC1
Scheme 2.
mixture of light petroleum:dichloromethane as eluent.
This solvent was then evaporated to dryness and the residue
was crystallized from ethanol to give 20-(3,4-dibenzylox-
ycinnamoyloxy)acetophenone (1) (4.6 g, yield: 58%). m.p.
108–109 8C (recrystallized from ethanol). 1H NMR:
d ¼ 2:56 (s, 3H, 2-CH3), 5.21 (s, 2H, 300-OCH2C6H5),
5.23 (s, 2H, 400-OCH2C6H5), 6.46 (d, J 15.8 Hz, 1H, H-
a), 6.94 (d, J 8.4 Hz, 1H, H-500), 7.14 (dd, J 8.4 and 2.0 Hz,
1H, H-600), 7.18 (dd, J 7.4 and 1.5 Hz, 1H, H-30), 7.19 (d, J
2.0 Hz, 1H, H-200), 7.26–7.49 (m, 11H, H-50 and H-2,3,4,5,6
of 300,400-OCH2C6H5), 7.56 (dt, J 7.4 and 1.6 Hz, 1H,
H-40), 7.78 (d, J 15.8 Hz, 1H, H-b), 7.83 (dd, J 7.7 and
1.6 Hz, 1H, H-60). 13C NMR: d ¼ 29:9 (C-2), 70.9 (400-
OCH2C6H5), 71.3 (300-OCH2C6H5), 113.8 (C-200), 114.1
(C-500), 114.5 (C-a), 123.5 (C-600), 123.8 (C-30), 126.0
(C-50), 127.1, 127.3, 127.4, and 128.0 (C-2,3,4,5,6 of
300,400-OCH2C6H5), 130.1 (C-60), 131.4 (C-10), 133.3 (C-
40), 136.6 and 136.8 (C-100 and C-1 of 300,400-OCH2C6H5),
147.2 (C-b), 148.9 (C-20), 149.2 (C-300), 151.5 (C-400),
165.4 (C=O), 197.9 (C-1). EI-MS: m/z (%) ¼ 478(7)
(Mꢀþ), 344(9), 343(34), 253(5), 251(3), 181(8), 163(2),
136(3), 121(6), 105(2), 92(11), 91(100), 77(4), 65(9),
63(3), 51(3). C31H26O5 (478.5): Calc. C, 77.81; H,
5.48. Found C, 77.81; H, 5.40.
2.2.3. 30,40-Dibenzyloxy-2-styrylchromone (3)
p-Toluenesulfonic acid monohydrate (0.38 g, 2.0 mmol)
was added to a solution of 1-(2-hydroxyphenyl)-5-(3,4-
dibenzyloxyphenyl)-3-hydroxy-2,4-pentadiene-1-one (2)
(1.9 g, 4 mmol) in dimethyl sulfoxide (30 ml). This
solution was heated, under nitrogen, at 90 8C, until the
complete consumption of the starting material. After that
period, the solution was poured into ice and water (100 ml)
and the solid obtained was removed by filtration. This solid
was dissolved in dichloromethane (50 ml) and the organic
layer washed with water (2 Â 100 ml). After evaporation of
the solvent to dryness, the residue was crystallized from
ethanol giving 30,40-dibenzyloxy-2-styrylchromone (3)
(1.6 g, yield: 85%). m.p. 161–163 8C (recrystallized from
1
ethanol). H NMR: d ¼ 5:22 (s, 2H, 40-OCH2C6H5), 5.23
(s, 2H, 30-OCH2C6H5), 6.29 (s, 1H, H-3), 6.58 (d, J
16.0 Hz, 1H, H-a), 6.96 (d, J 8.4 Hz, 1H, H-50), 7.14
(dd, J 8.4 and 2.0 Hz, 1H, H-60), 7.19 (d, J 2.0 Hz,
1H, H-20), 7.33–7.43 (m, 10H, H-2,3,4,5,6 of 30,40-
OCH2C6H5), 7.48 (dd, J 8.3 and 7.6 Hz, 1H, H-6), 7.51
(d, J 16.0 Hz, 1H, H-b), 7.52 (d, J 8.2 Hz, 1H, H-8), 7.68
(ddd, J 8.2, 7.6 and 1.6 Hz, 1H, H-7), 8.20 (dd, J 8.3 and
1.6 Hz, 1H, H-5). 13C NMR: d ¼ 71:0 (40-OCH2C6H5),
71.4 (30-OCH2C6H5), 110.1 (C-3), 113.4 (C-20), 114.4 (C-
50), 117.8 (C-8), 118.3 (C-a), 122.4 (C-60), 124.1 (C-10),
124.9 (C-6), 125.6 (C-5), 127.2, 127.3, 128.0 and 128.5 (C-
2,3,4,5,6 of 30,40-OCH2C6H5), 133.6 (C-7), 136.7 (C-b),
136.9 (C-10), 136.9 (C-1 of 30,40-OCH2C6H5), 149.1 (C-30),
150.7 (C-40), 156.0 (C-9), 162.0 (C-2), 178.4 (C-4). EI-MS:
m/z (%) ¼ 460 (22) (Mꢀþ), 370(11), 369(23), 352(4),
2.2.2. 1-(2-Hydroxyphenyl)-5-(3,4-dibenzyloxyphenyl)-
3-hydroxy-2,4-pentadiene-1-one (2)
Potassium hydroxide (powder, 1.0 g, 25 mmol) was
added to a solution of 20-(3,4-dibenzyloxycinnamoylox-
yacetophenone (1) (2.4 g, 5 mmol) in dimethyl sulfoxide
(30 ml). The solution was stirred, under nitrogen, at room
temperature for 2 h. Following that period the solution
was poured into ice and water (200 ml), and the pH
was adjusted to 4 with diluted hydrochloric acid. The
solid obtained was removed by filtration, dissolved in